The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effectiveness of ASCO’s adverse event reporting decision aid: Results from an interventional study.
 
Kathryn Finch Mileham
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Merck
Research Funding - Celgene
 
Andrea D. Buchmeier
Stock and Other Ownership Interests - Hospital Corporation of America
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Meredith Kathleen Chuk
No Relationships to Disclose
 
Courtney Davis
No Relationships to Disclose
 
Anne Marie Forest
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie
Consulting or Advisory Role - Deciphera; Okava Pharmaceuticals; Tactical Therapeutics; TYME
 
Patricia A. Hurley
No Relationships to Disclose
 
Laura Levit
No Relationships to Disclose
 
Raymond P. Perez
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Caroline Schenkel
No Relationships to Disclose
 
Julie Vose
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Epizyme; Janssen Scientific Affairs; Karyopharm Therapeutics; Kite/Gilead; Legend Biotech; Miltenyi Biotec; Nordic Nanovector; Novartis; Roche; Sandoz; Vaniam Group; Verastem
Consulting or Advisory Role - Bio Connections
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Seagen (Inst)